Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes.

about

Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes.

Item

http://www.wikidata.org/entity/Q45028902

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Antithrombotic therapy in medi ...... tion acute coronary syndromes.

@en

Antithrombotic therapy in medi ...... tion acute coronary syndromes.

@nl

type

Item

label

Antithrombotic therapy in medi ...... tion acute coronary syndromes.

@en

Antithrombotic therapy in medi ...... tion acute coronary syndromes.

@nl

prefLabel

Antithrombotic therapy in medi ...... tion acute coronary syndromes.

@en

Antithrombotic therapy in medi ...... tion acute coronary syndromes.

@nl

P1476

Antithrombotic therapy in medi ...... tion acute coronary syndromes.

@en

P2093

Paul A Gurbel

http://www.w3.org/2001/XMLSchema#string

Udaya S Tantry

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial

Incidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease

Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial.

Absorption, distribution, metabolism, and excretion of ticagrelor in healthy subjects.

P304

882-892

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HEARTJNL-2014-306695

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26944654

http://www.w3.org/2001/XMLSchema#string